Toggle Main Menu Toggle Search

Open Access padlockePrints

Erratum to ‘Highly accurate, noninvasive early identification of infants with a filaggrin loss-of-function mutation by in vivo Raman spectroscopy, followed from birth to 12 months’ [Annals of Allergy, Asthma & Immunology, 134;4 (2025) 457–464, (S1081120625000109), (10.1016/j.anai.2025.01.010)]

Lookup NU author(s): Professor John Common

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 The Authors. The publisher regrets in the original published version of this article, the following errors were introduced during the copyediting process by the Suppliers. The text originally published “Loss-of-function (LoF) mutations…are the most well-known genetic factors in AD pathogenesis”. Has been corrected to “Loss-of-function (LoF) mutations…are the strongest known genetic factors in AD pathogenesis”. The text originally published “FLGmut analysis and Raman spectroscopic NMF analysis of infants were performed after the…”. Has been corrected to “FLGmut analysis and Raman spectroscopic NMF analysis of infants were performed during the…”. The text originally published “For infants with a relatively thin pSC, measurements were performed at a depth of 35 m below the skin surface”. Has been corrected to “For infants with a relatively thin pSC, measurements were performed at a depth of 35 µm below the skin surface”. The text originally published “For parents, measurements were performed 70 m below the skin surface”. Has been corrected to “For parents, measurements were performed 70 µm below the skin surface". The text originally published “NMF2w is the average NMF content at 2 weeks after birth, at which the MF content…”. Has been corrected to “NMF2w is the average NMF content at 2 weeks after birth, at which the NMF content…”. The text originally published “pSC-NMF concentrations at 0 to 4 days after birth and at 2, 4, 8, 6, and 12 months after birth”. Has been corrected to “pSC-NMF concentrations at 0 to 4 days after birth; 2, 4, and 8 weeks after birth; and 6 and 12 months after birth”. The text originally published “253 patients had buccal swabs used for FLG genotyping”. Has been corrected to “253 patients had a buccal swab taken for FLG genotyping”. The text originally published “NMF levels plateaued within the first 2 weeks of life”. Has been corrected to “Thenar NMF levels plateaued within the first 2 weeks of life”. The text originally published “In conclusion, we demonstrated that Raman-derived NMF measurements can be used as a quick, noninvasive, highly accurate surrogate for FLG genotyping in parents and newborn infants from day 0”. Has been corrected to “In conclusion, we have demonstrated that Raman-derived NMF measurements can be used as a quick, entirely non-invasive, highly accurate surrogate for FLG genotyping in parents and in newborn infants from day 0”. The text originally published “It reaches a maximum at 2 to 4 after birth”. Has been corrected to “It reaches a maximum at 2 to 4 weeks after birth”. These errors bear no reflection on the article or its authors. The publisher apologizes to the authors and the readers for this unfortunate error.


Publication metadata

Author(s): Puppels GJ, Hourihane JO, Nico C, Chaoimh CN, Wong C, Common JE, Caspers PJ, Irvine AD

Publication type: Note

Publication status: Published

Journal: Annals of Allergy, Asthma and Immunology

Year: 2025

Volume: 135

Issue: 1

Pages: 124-124

Print publication date: 01/07/2025

Online publication date: 18/05/2025

Acceptance date: 02/04/2018

ISSN (print): 1081-1206

ISSN (electronic): 1534-4436

Publisher: American College of Allergy, Asthma and Immunology

URL: https://doi.org/10.1016/j.anai.2025.04.014

DOI: 10.1016/j.anai.2025.04.014

PubMed id: 40382729


Share